1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Cerebral Vasospasm Global Clinical Trials Review, H1, 2014

Cerebral Vasospasm Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Cerebral Vasospasm Global Clinical Trials Review, H1, 2014" provides data on the Cerebral Vasospasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral Vasospasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cerebral Vasospasm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Cerebral Vasospasm Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Cerebral Vasospasm 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Cerebral Vasospasm to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Cerebral Vasospasm to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Cerebral Vasospasm 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Cerebral Vasospasm Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Pharmalab India Pvt. Ltd. 30
Clinical Trial Overview of Pharmalab India Pvt. Ltd. 30
Actelion Ltd 31
Clinical Trial Overview of Actelion Ltd 31
Clinical Trial Overview of Top Institutes / Government 32
The University of Nottingham 32
Clinical Trial Overview of The University of Nottingham 32
Vanderbilt University 33
Clinical Trial Overview of Vanderbilt University 33
Medical University of Vienna 34
Clinical Trial Overview of Medical University of Vienna 34
University of Massachusetts 35
Clinical Trial Overview of University of Massachusetts 35
Tokyo Women's Medical University 36
Clinical Trial Overview of Tokyo Women's Medical University 36
YAMAGUCHI UNIVERSITY 37
Clinical Trial Overview of YAMAGUCHI UNIVERSITY 37
Rush University Medical Center 38
Clinical Trial Overview of Rush University Medical Center 38
University of Washington 39
Clinical Trial Overview of University of Washington 39
University of Florida 40
Clinical Trial Overview of University of Florida 40
Johann Wolfgang Goethe University Hospitals 41
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 41
Five Key Clinical Profiles 42
Appendix 60
Abbreviations 60
Definitions 60
Research Methodology 61
Secondary Research 61
About GlobalData 62
Contact Us 62
Disclaimer 62
Source 62

List of Tables
Cerebral Vasospasm Therapeutics, Global, Clinical Trials by Region, 2014* 6
Cerebral Vasospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Cerebral Vasospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Cerebral Vasospasm Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Cerebral Vasospasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Cerebral Vasospasm Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Cerebral Vasospasm Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Cerebral Vasospasm Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Cerebral Vasospasm to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Cerebral Vasospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Cerebral Vasospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Cerebral Vasospasm to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Cerebral Vasospasm Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Cerebral Vasospasm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Cerebral Vasospasm Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Cerebral Vasospasm Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Cerebral Vasospasm Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Cerebral Vasospasm Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Cerebral Vasospasm Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Cerebral Vasospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Cerebral Vasospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Cerebral Vasospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Cerebral Vasospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Cerebral Vasospasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Cerebral Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmalab India Pvt. Ltd., 2014* 30
Cerebral Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014* 31
Cerebral Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Nottingham, 2014* 32
Cerebral Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 33
Cerebral Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 34
Cerebral Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2014* 35
Cerebral Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Women's Medical University, 2014* 36
Cerebral Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by YAMAGUCHI UNIVERSITY, 2014* 37
Cerebral Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2014* 38
Cerebral Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 39
Cerebral Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2014* 40
Cerebral Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2014* 41

List of Figures
Cerebral Vasospasm Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Cerebral Vasospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Cerebral Vasospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Cerebral Vasospasm Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Cerebral Vasospasm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Cerebral Vasospasm Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Cerebral Vasospasm to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Cerebral Vasospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Cerebral Vasospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Cerebral Vasospasm to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Cerebral Vasospasm Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Cerebral Vasospasm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Cerebral Vasospasm Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Cerebral Vasospasm Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Cerebral Vasospasm Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Cerebral Vasospasm Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Cerebral Vasospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Cerebral Vasospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Cerebral Vasospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Cerebral Vasospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Cerebral Vasospasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 61

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.